Tickerplace logo

Tickerplace

Bicara Therapeutics Inc. Common Stock logo

BCAXBicara Therapeutics Inc. Common Stock

BCAX Stock Price, Valuation & Chart | Bicara Therapeutics Inc. Common Stock

Compare
$23.560+0.14 (+0.60%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyBCAX intrinsic valueBCAX calculated fair value vs price
OverviewFinancialsDividendsRatios

BCAX Historical price chart

BCAX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.55B
PE Ratio-7.6
EPS-3.1
Trading Volume517.60K
Today's High/Low24.35/22.82
Dividend Yield0.00
52 Week High/Low30.99/10.29
Shares Outstanding65.70M
BCAX Financial Statement
BCAX Analyst ratings
BCAX Analysis & performance metrics

BCAX Company profile

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional…

BCAX Management team

Management
Sathish Hasige Ph.D.
Senior Vice President and Head of Technical Operations & Supply Chain
Ryan Cohlhepp Pharm.D.COO
President, Chief Operating Officer & Director
Lara S. Meisner J.D.
Chief Legal Officer & Corporate Secretary
Jeltje Schulten M.B.A., M.D.
Senior Vice President of Clinical & Medical Affairs
Rachel Salazar
SVice President of R&D Strategy and Operations
Jean-Paul Rodrique
Senior Vice President & Global Head of Quality Assurance
Claire Mazumdar Clemon M.B.A., Ph.D.CEO
Chief Executive Officer & Director
David Raben M.D.
Chief Medical Officer
Total 8 executives

BCAX Frequently asked questions

What is Bicara Therapeutics Inc. Common Stock (BCAX) Stock Price?

Current stock price of Bicara Therapeutics Inc. Common Stock (BCAX) stock is $23.560. The stock price is +0.60% higher in the session. The intraday range can be seen from this page. Volume of Bicara Therapeutics Inc. Common Stock (BCAX) stock is 517.60K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Bicara Therapeutics Inc. Common Stock (BCAX) stock price going up or down today?

The stock price of Bicara Therapeutics Inc. Common Stock (BCAX) can change with earnings, company news, and overall market sentiment. Bicara Therapeutics Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bicara Therapeutics Inc. Common Stock stock expensive at its current price?

Whether Bicara Therapeutics Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BCAX on this page is -7.60. EPS on this page is -3.10. Compare those figures with peers and growth expectations before deciding if the current Bicara Therapeutics Inc. Common Stock price is justified.

How has the stock price of Bicara Therapeutics Inc. Common Stock (BCAX) performed historically?

Historical performance for Bicara Therapeutics Inc. Common Stock (BCAX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BCAX reacted to past earnings and market events.

Should I buy Bicara Therapeutics Inc. Common Stock (BCAX) stock, at this price?

Buying Bicara Therapeutics Inc. Common Stock (BCAX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.